2-[4-(4,6-Di-morpholin-4-yl-[1,3,5]triazin-2-yl)-phenylamino]-3H-benzoimidazole-5-carboxylic acid ((S)-1-carbamoyl-ethyl)-amide

ID: ALA4794018

Chembl Id: CHEMBL4794018

PubChem CID: 162672741

Max Phase: Preclinical

Molecular Formula: C28H32N10O4

Molecular Weight: 572.63

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1)C(N)=O

Standard InChI:  InChI=1S/C28H32N10O4/c1-17(23(29)39)30-25(40)19-4-7-21-22(16-19)33-26(32-21)31-20-5-2-18(3-6-20)24-34-27(37-8-12-41-13-9-37)36-28(35-24)38-10-14-42-15-11-38/h2-7,16-17H,8-15H2,1H3,(H2,29,39)(H,30,40)(H2,31,32,33)/t17-/m0/s1

Standard InChI Key:  VBGYJJWVQQNQDI-KRWDZBQOSA-N

Alternative Forms

  1. Parent:

    ALA4794018

    ---

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CD Tclin PI3-kinase p110-delta subunit (6699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNE-2 (385 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 572.63Molecular Weight (Monoisotopic): 572.2608AlogP: 1.44#Rotatable Bonds: 8
Polar Surface Area: 176.51Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.54CX Basic pKa: 7.01CX LogP: 2.81CX LogD: 2.65
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -1.35

References

1. Wu TT,Guo QQ,Chen ZL,Wang LL,Du Y,Chen R,Mao YH,Yang SG,Huang J,Wang JT,Wang L,Tang L,Zhang JQ.  (2020)  Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors.,  204  [PMID:32717477] [10.1016/j.ejmech.2020.112637]

Source